Is “good” cholesterol always good?

LDL, or low-density lipoprotein, is commonly called “bad” cholesterol because elevated levels can contribute to plaque in artery walls. HDL, or high-density lipoprotein, has long been described as “good” because it helps transport cholesterol away from tissues. That shorthand is useful, but it leaves out important complexity.

A high HDL result should not be treated as a guarantee of protection, and a low result should not be considered in isolation. Evidence supporting the reduction of elevated LDL is much stronger than evidence that deliberately raising HDL alone prevents cardiovascular events. Contemporary care therefore looks beyond a single HDL value to a person’s broader risk profile.

Association is not the same as cause

Observational research has often found that people with higher HDL levels have lower cardiovascular risk. An association, however, does not prove that HDL itself causes the difference—or that increasing the laboratory value with a supplement or medication will produce the expected benefit.

Low HDL often appears alongside other factors that can affect risk, including elevated triglycerides, insulin resistance, smoking, limited physical activity and certain patterns of LDL particles. This makes it difficult to separate HDL from the metabolic circumstances surrounding it.

Why HDL quality may matter

HDL is not one uniform substance. Particles differ in size, composition and function, and they interact with other lipids and inflammatory processes. Researchers continue to study whether the way HDL functions is more informative than the amount measured in a standard lipid panel.

This complexity helps explain why a treatment that increases HDL cholesterol may not necessarily reduce heart attacks or strokes. A changed test value is a biological effect, but it is not automatically evidence of improved health outcomes.

What about niacin and other drugs?

Earlier strategies sometimes aimed to raise HDL directly. Trials of some HDL-raising drugs did not deliver the expected cardiovascular benefit, and certain approaches introduced unwanted effects. Prescription niacin can alter several lipid values, but it should not be taken for cholesterol without clinical supervision.

Statins are generally used to lower LDL rather than to raise HDL. Whether medication is appropriate depends on overall cardiovascular risk, existing disease, laboratory results, potential side effects and a clinician’s assessment—not on HDL alone.

How to respond to a low HDL result

Do not chase an isolated target or start a supplement on the strength of one test. Ask how the result fits with the rest of your lipid panel and health history. In selected situations, a clinician may consider repeat testing or additional evaluation, but advanced testing is not necessary for everyone.

Habits that support cardiovascular health remain worthwhile regardless of how much they change HDL. Regular exercise, avoiding tobacco, eating a varied dietary pattern, sleeping adequately and working toward an appropriate weight can affect health through multiple pathways. If stopping tobacco is difficult, structured support can help; this guide to exercise while stopping smoking offers additional context. For weight management, focus on sustainable practices rather than rapid change; see losing weight and keeping it off.

Alcohol should not be started as a way to raise HDL. Its risks and effects vary, and apparent changes in a laboratory number do not make drinking a preventive treatment. Read more about what moderation means.